7-day point prevalence | n = 243 | n = 2953 | 0.326 |
46 (18.9) | 488 (16.5) | |
Male | n = 90 | n = 1180 | 0.322 |
20 (22.2) | 212 (18.0) | |
Female | n = 153 | n = 1770 | 0.643 |
26 (17.0) | 275 (15.5) | |
(p Value within group) | (0.315) | (0.085) | |
30-day point prevalence | n = 243 | n = 2953 | 0.254 |
41 (16.9) | 419 (14.2) | |
Male | n = 90 | n = 1180 | 0.231 |
18 (20.0) | 181 (15.3) | |
Female | n = 153 | n = 1770 | 0.539 |
23 (15.0) | 237 (13.4) | |
(p Value within group) | (0.376) | (0.146) | |
6-month prolonged abstinence | n = 243 | n = 2953 | 0.293 |
26 (10.7) | 259 (8.8) | |
Male | n = 90 | n = 1180 | 0.041 |
15 (16.7) | 111 (9.4) | |
Female | n = 153 | n = 1770 | 0.759 |
11 (7.2) | 147 (8.3) | |
(p Value within group) | (0.030) | (0.319) | |